34 results
8-K
EX-99.1
IVVD
Invivyd Inc
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
as cash equivalents are presented as either short-term or long-term investments based on both their maturities as well as the time period the Company … of the Company’s stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional
8-K
EX-10.1
IVVD
Invivyd Inc
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
material change in the capital stock, short-term debt or long-term debt of the Company and its Subsidiaries, taken as a whole (other than … rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse Effect. The Company has
8-K
EX-99.1
IVVD
Invivyd Inc
11 Sep 23
Other Events
7:10am
; 3. Marzolini Clin Pharmacol Ther 2022 6
PREVENTION OF COVID-19 IN VULNERABLE POPULATIONS PRESENTS A COMPELLING, POTENTIAL LONG-TERM VALUE … COVID-19 is a compelling, potential long-term value proposition Invivyd is rapidly executing on its VYD222 clinical development plan, with positive
8-K
EX-99.1
4z1nb7rl5g1dgcez
29 Jun 23
Other Events
7:08am
8-K
EX-99.1
1o1m9d6f85c651h
2 May 23
Departure of Directors or Certain Officers
7:37am
DEF 14A
3m3qddu4
10 Apr 23
Definitive proxy
4:07pm
PRE 14A
6bm0a6nzzz04h
31 Mar 23
Preliminary proxy
4:36pm
8-K
EX-99.3
xe0cz g5r5
12 Sep 22
Adagio Therapeutics Announces Corporate Name Change to Invivyd
7:46am
8-K
EX-99.1
ehshlgcm
15 Aug 22
Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
7:22am
DEFC14C
mmol5y haqtba
2 Jun 22
Information statement in contested solicitation
4:24pm
PRER14C
7v3b5hxb
31 May 22
Preliminary revised information
5:09pm
PREC14C
g2shl
19 May 22
Preliminary information statement in contested solicitation
5:05pm
DEFC14A
nasz1vzbly1i9b26
29 Apr 22
Proxy in contested solicitation
4:02pm
PRRN14A
c3pcpx
27 Apr 22
Revised preliminary proxy statement filed by non-management
1:13pm